Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Trevisani

Showing results (51-60 of 208) with videos related to

Pageof 21
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 6, 2016
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Alberta Cappelli, et al.
Journal of Hepatology|January 24, 2024
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposalFranco Trevisani, Alessandro Vitale, Masatoshi Kudo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular CarcinomaNaim Alkhouri, Michio Imawari, Namiki Izumi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 6, 2017
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patientsAlessandro Cucchetti, Gennaro D'Amico, Franco Trevisani, et al.
Hepatology (Baltimore, Md.)|February 26, 2009
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selectionMatteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Annals of Surgery|July 30, 2009
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 23, 2013
Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?Rita Golfieri, Matteo Renzulli, Cristina Mosconi, et al.
Journal of Hepatology|June 13, 2024
Reply to: "Evidence and choice: The BCLC vision for tailoring clinical decision-making"Franco Trevisani, Alessandro Vitale, Agostino Colli, et al.
Internal and Emergency Medicine|February 18, 2011
Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndromeAntonio Di Micoli, Daniela Buccione, Daniela Degli Esposti, et al.
Journal of Hepatology|March 29, 2003
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shuntFranco Trevisani, Manuela Merli, Francesco Savelli, et al.
Pageof 21

Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 6, 2016
Cost-effectiveness of doxorubicin-eluting beads versus conventional trans-arterial chemo-embolization for hepatocellular carcinomaAlessandro Cucchetti, Franco Trevisani, Alberta Cappelli, et al.
Journal of Hepatology|January 24, 2024
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposalFranco Trevisani, Alessandro Vitale, Masatoshi Kudo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 25, 2020
Lusutrombopag Is Safe and Efficacious for Treatment of Thrombocytopenia in Patients With and Without Hepatocellular CarcinomaNaim Alkhouri, Michio Imawari, Namiki Izumi, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 6, 2017
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patientsAlessandro Cucchetti, Gennaro D'Amico, Franco Trevisani, et al.
Hepatology (Baltimore, Md.)|February 26, 2009
Down-staging of hepatocellular carcinoma prior to liver transplantation: the power of selectionMatteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Annals of Surgery|July 30, 2009
Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?Matteo Ravaioli, Gian Luca Grazi, Matteo Cescon, et al.
Journal of Vascular and Interventional Radiology : JVIR|February 23, 2013
Hepatocellular carcinoma responding to superselective transarterial chemoembolization: an issue of nodule dimension?Rita Golfieri, Matteo Renzulli, Cristina Mosconi, et al.
Journal of Hepatology|June 13, 2024
Reply to: "Evidence and choice: The BCLC vision for tailoring clinical decision-making"Franco Trevisani, Alessandro Vitale, Agostino Colli, et al.
Internal and Emergency Medicine|February 18, 2011
Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndromeAntonio Di Micoli, Daniela Buccione, Daniela Degli Esposti, et al.
Journal of Hepatology|March 29, 2003
QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shuntFranco Trevisani, Manuela Merli, Francesco Savelli, et al.
Pageof 21